Drugs / Levomethadyl acetate

Trials 3 · a red edge is where a trial was stopped

199519961997199819992000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 22 trials
Phase 2 NCT00218127 Nov 2001 → Jul 2005 heroin dependence National Institute on Drug Abuse (NIDA) Completed No outcome recorded
Phase 2 NCT00344812 Jan 1996 → Jun 1998 opiate dependence Johns Hopkins University Completed No outcome recorded
Phase 41 trial
Phase 4 NCT00000300 Mar 1995 → ? opiate dependence University of California, Los Angeles Completed No outcome recorded

Evidence & citations 14 cited values

Every value below carries the sentence it was read from. 4 sources stand behind the page.

FieldValueCited text
Known as Levomethadyl acetate “In a 17-week randomized study of 220 patients, we compared levomethadyl acetate (75 to 115 mg), buprenorphine (16 to 32 mg), and high-dose (60 to 100 mg) and low-dose (20 mg)...” PMID 11058673 Nov 2000
Known as LAAM ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000300
Known as Levacetilmetadol ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as Levacetylmethadol ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as Levacetylmethadol hydrochloride ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as Levo-alphacetylmethadol ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as Levoacetyl Methadol ClinicalTrials.gov intervention name — accepted as the source's own label NCT00218127
Known as Levomethadyl acetate hcl ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as LEVOMETHADYL ACETATE HYDROCHLORIDE ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as MK-790 ChEMBL registry synonym — accepted as the source's own label CHEMBL1514
Known as ORLAAM “The purpose of this study is to determine the effectiveness of levoacetyl methadol (ORLAAM) in treating heroin dependent individuals.” NCT00218127
Action Activate “Mu opioid receptor agonist” CHEMBL1514
Modality Small molecule CHEMBL1514
Target OPRM1 “Mu opioid receptor agonist” CHEMBL1514